Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs Original Zoledronic Acid in Postmenopausal Osteoporosis
NCT03158246Phase 4Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jun 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in postmenopausal osteoporosis, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT03158246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03158246.